OBI Pharma, Inc. (TPEX: 4174)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
76.30
+0.80 (1.06%)
Sep 11, 2024, 10:00 AM CST

OBI Pharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-2,155-1,046-1,614-1,531-1,378-1,407
Upgrade
Depreciation & Amortization
230.44244.86240.92208.75214.53197.06
Upgrade
Other Amortization
0.584.15.697.5217.3116.84
Upgrade
Loss (Gain) From Sale of Assets
-43.530.39-0.0115.08--
Upgrade
Asset Writedown & Restructuring Costs
-5.96----
Upgrade
Loss (Gain) From Sale of Investments
-28.5-879.321.02-0.37-54148.36
Upgrade
Loss (Gain) on Equity Investments
286.43163.58----
Upgrade
Stock-Based Compensation
77.13119.214954.0276.82153.93
Upgrade
Other Operating Activities
-167.7-201.73-310.03-195.51-98.03-315.15
Upgrade
Change in Accounts Receivable
2.79-4.441.43-2.010.07-0.47
Upgrade
Change in Inventory
-7.75-3.96-9.74-2.2-3.160.91
Upgrade
Change in Accounts Payable
-1.64-0.370.620.37-0.020.11
Upgrade
Change in Unearned Revenue
4.423.133.16--77.6477.64
Upgrade
Change in Other Net Operating Assets
-62.3-57.89-87.84-1.5720.7510.53
Upgrade
Operating Cash Flow
-1,865-1,653-1,620-1,064-1,609-1,117
Upgrade
Capital Expenditures
-133.58-101.93-254.65-241.33-182.68-69.54
Upgrade
Sale of Property, Plant & Equipment
144.830.20.05---
Upgrade
Cash Acquisitions
---472.65--
Upgrade
Divestitures
-30.41-564.08----
Upgrade
Sale (Purchase) of Intangibles
-6.02-6.23-45.91-3.86-2.96-4.95
Upgrade
Investment in Securities
283.45-2,110109.29-140--
Upgrade
Other Investing Activities
8.24-13.1721.33-4.79-10.26-4.22
Upgrade
Investing Cash Flow
266.51-2,795-169.8982.68-195.9-78.71
Upgrade
Short-Term Debt Issued
--15.71-9.47-
Upgrade
Total Debt Issued
50.04-15.71-9.47-
Upgrade
Short-Term Debt Repaid
--11.4--9.47--
Upgrade
Long-Term Debt Repaid
--51.61-59.31-58.07-54.6-37.31
Upgrade
Total Debt Repaid
-63.84-63.01-59.31-67.54-54.6-37.31
Upgrade
Net Debt Issued (Repaid)
-13.8-63.01-43.61-67.54-45.13-37.31
Upgrade
Issuance of Common Stock
3.3117.613,15016.9922.942,026
Upgrade
Repurchase of Common Stock
------93.46
Upgrade
Other Financing Activities
-0652.47903.59214.3305.29-
Upgrade
Financing Cash Flow
-10.5607.074,010163.75283.091,895
Upgrade
Foreign Exchange Rate Adjustments
5.91-0.568.53-8.060.54-1.84
Upgrade
Net Cash Flow
-1,603-3,8422,229-826.12-1,522697.05
Upgrade
Free Cash Flow
-1,998-1,755-1,874-1,306-1,792-1,187
Upgrade
Free Cash Flow Margin
-3442.65%-4223.71%-39786.71%-6956.13%-1272.04%-21245.99%
Upgrade
Free Cash Flow Per Share
-8.72-7.66-8.44-6.56-9.02-6.19
Upgrade
Cash Interest Paid
11.073.743.993.84.183.9
Upgrade
Cash Income Tax Paid
--7.28-9.56-15.154.392.48
Upgrade
Levered Free Cash Flow
-1,279-1,228-1,406-1,002-770.41-665.37
Upgrade
Unlevered Free Cash Flow
-1,272-1,223-1,403-999.39-767.8-662.93
Upgrade
Change in Net Working Capital
52.91176.88171.4-48.01-25.37-29.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.